{"id":915468,"date":"2026-09-30T15:34:10","date_gmt":"2026-09-30T15:34:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/915468\/"},"modified":"2026-09-30T15:34:10","modified_gmt":"2026-09-30T15:34:10","slug":"uae-approves-drug-that-helps-control-production-of-excess-red-blood-cells","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/915468\/","title":{"rendered":"UAE approves drug that helps control production of excess red blood cells"},"content":{"rendered":"<p class=\"dropcap\">Adults with a rare blood disorder that causes their bodies to produce too many red blood cells could need fewer procedures to remove blood following <a href=\"https:\/\/www.khaleejtimes.com\/uae\/uae-medicine-approvals-2026-rare-drugs-patients\" rel=\"nofollow noopener\" target=\"_blank\">the UAE\u2019s approval of a new medicine<\/a>.<\/p>\n<p><a href=\"https:\/\/www.khaleejtimes.com\/uae\/first-in-the-world-approve-pill-non-segmental-vitiligo\" rel=\"nofollow noopener\" target=\"_blank\">The Emirates Drug Establishment (EDE)<\/a> has approved MIMRYLO, also known as rusfertide, for adults with polycythemia vera. According to the establishment, the UAE is the second country globally to authorise the treatment.<\/p>\n<p>The condition causes the body to make more red blood cells than it needs. These extra cells make the blood thicker and increase the risk of blood clots and other complications.<\/p>\n<p><a href=\"https:\/\/whatsapp.com\/channel\/0029Va5dROu3bbUxk7Jh2503\" class=\"whatsapp-style\" target=\"_blank\" rel=\"nofollow noopener\">Stay up to date with the latest news. Follow KT on WhatsApp Channels.<\/a><\/p>\n<p>What changes for patients<\/p>\n<p>One way doctors manage the condition is by regularly removing blood to bring red blood cell levels under control. This procedure, called therapeutic phlebotomy, may need to be repeated depending on the patient\u2019s condition.<\/p>\n<p>MIMRYLO helps control the production of excess red blood cells by regulating how the body uses iron. According to Takeda, clinical trials showed that the medicine helped control red blood cell levels, reduced the need for blood-removal procedures and improved fatigue.<\/p>\n<p>The approval gives doctors another treatment option for adults living with the condition. However, the UAE announcement did not specify when patients would be able to receive the medicine, its local price or whether it would be covered by insurance.<\/p>\n<p>Another treatment option<\/p>\n<p>Dr Fatima Al Kaabi, director general of EDE, said that the approval reflected the establishment\u2019s commitment to helping patients access advanced treatments through a scientific assessment process that prioritises their safety.<\/p>\n<p>She said that this was particularly important for rare diseases, where some patients still have limited treatment options. She added that timely regulatory decisions could help improve care and support better outcomes.<\/p>\n<p>Hernan Purcell, regional general manager for the Middle East and Turkey at Takeda Pharmaceuticals, said that the approval marked an important milestone for people living with polycythemia vera. He also highlighted EDE\u2019s role in supporting access to new treatments.<\/p>\n<p>The medicine comes in single-dose vials containing a powder that must be prepared before use. EDE said that it should be administered under the supervision of a healthcare provider experienced in managing the condition.<\/p>\n<p>The establishment urged patients to follow their doctor\u2019s prescribed treatment plan and attend regular follow-up appointments to help keep the condition under control.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/09\/WhatsApp_Image_2025_07_12_at_12_24_34.jpeg\" alt=\"SM Ayaz Zakir\" height=\"124\" width=\"124\" fetchpriority=\"high\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"Adults with a rare blood disorder that causes their bodies to produce too many red blood cells could&hellip;\n","protected":false},"author":2,"featured_media":915469,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[49,48,84,377],"class_list":["post-915468","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-ca","tag-canada","tag-health","tag-medication"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/915468","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=915468"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/915468\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/915469"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=915468"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=915468"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=915468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}